Clinical Trials Logo
  1. Home
  2. Type B Aortic Dissection
  3. NCT01984905

Study of Prognostic Factors in Aortic Dissection Type B — TEDAC  

Type B Aortic Dissection Clinical Trial

Official title:
Exploratory Study of Prognostic Factors in Aortic Dissection Type B: Role of Imaging (18F-FDG PET-Scan and Angioscan) and Biomarkers

Clinical Trial Summary

Clinical outcomes of chronic type B aortic dissections are unknown, especially in case of false lumen expansion and risk of rupture. Data of literature give us some indications about prognosis. The 1-year survival rate is about 80%, but we deplore the 25% rate of mortality at 3 years despite follow-up.The only known predictive factors are the initial diameter of more than 4 cm and the persistence of a false lumen patent.However, actual means of follow-up do not allow to predict severe complications. The aim of the sudy is to propose a diagnostic and preventive strategy for the follow-up of chronic type B aortic dissections treated medically.

The primary objective is then to evaluate the prognostic role of 18-FDG-PET Scan in such patients in order to predict the risk of aortic diameter growth of more than 5 mm in 1 year and/or of an aortic dissections extension at 1 year. The secondary objectives are to evaluate the link between fibrosis biomarkers MMP et TIMP) and the results of imaging results (evolution of diameter and extension and results of PET-Scan imaging) Methods: 100 patients to be included in 3 years History of chronic type B aortic dissection, treated medically, evolving since more than 1 month and less than 5 years.

Expected results: Prognostic contribution of 18FDG-PET-Scan and biomarkers for the identification of patients at high risk of evolution. Elaboration of a decisional algorithm about follow-up modalities of chronic aortic dissections. Demonstration of a correlation between aortic diameter growth or aortic dissection extension and intensity of marker fixation with 18-FDG-PET-Scan.

Clinical Trial Description

n/a

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01984905
Study type Observational
Source University Hospital, Caen
Contact
Status Recruiting
Phase N/A
Start date October 2013
Completion date December 2017
View Details
See also
  Status Clinical Trial Phase
Completed NCT00908388 - Evaluation of the GORE Conformable TAG® Thoracic Endoprosthesis for Treatment of Acute Complicated Type B Aortic Dissection N/A
Recruiting NCT05479305 - Evaluation of the Valiant Captivia Physician Fenestrated Stent Graft System in Aortic Arch and Descending Thoracic Aorta Pathologies N/A
Completed NCT01407159 - A Study in SurvIvors of Type B Aortic Dissection Undergoing Stenting N/A
Not yet recruiting NCT05349071 - PreOperative Methylprednisolone on Thoracic Endovascular Repair for Reducing Post-implantation Syndrome (POMTEVAR) N/A
Not yet recruiting NCT06289777 - Aortic Remodeling After Endovascular Management of Type B Aortic Dissection.
Withdrawn NCT02816333 - Korean Registry of Thoracic Endovascular Aortic Repair Timing for Type B Aortic Dissection (K-TEAM Study): A Prospective Multicenter Registry
Enrolling by invitation NCT03845829 - LSA Reconstruction With Laser Fenestration During the TEVAR N/A
Active, not recruiting NCT04765605 - Guo's Subclavian Artery Reconstruction: The Prospective, Multiple Center Study of WeFlow-Tbranch Stent Graft System(GUEST Study) N/A
Recruiting NCT06087029 - IMPRoving Outcomes in Vascular DisEase- Aortic Dissection N/A